K2X Technology & Life Science, Inc. Share Price
Equities
KBPH
US5015722003
Financial & Commodity Market Operators
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | -45.65% | -.--% | -.--% |
Sales 2020 | 0.01 1.13 | Sales 2021 | - | Capitalization | 18.62M 1.49B |
---|---|---|---|---|---|
Net income 2020 | - 0 | Net income 2021 | - 0 | EV / Sales 2020 | 926,138,940 x |
Net cash position 2020 | 28.01K 2.24M | Net cash position 2021 | 8.26M 660M | EV / Sales 2021 | - |
P/E ratio 2020 |
-17
x | P/E ratio 2021 |
95
x | Employees | 1 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 53.62% |
1 day | -45.65% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Russo
CEO | Chief Executive Officer | 81 | 04/03/99 |
Director of Finance/CFO | 75 | 14/03/18 | |
Investor Relations Contact | - | 31/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Russo
CEO | Chief Executive Officer | 81 | 04/03/99 |
Peter Staple
BRD | Director/Board Member | 72 | 07/01/21 |
Jon Saxe
BRD | Director/Board Member | 88 | 07/01/21 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 16.33M | |
+1.13% | 74.99B | |
-4.62% | 58.96B | |
-2.87% | 36.13B | |
+2.94% | 34.83B | |
-27.01% | 12.23B | |
+7.63% | 9.4B | |
-31.26% | 7.67B | |
+13.18% | 7.4B | |
-4.78% | 7.37B |
- Stock Market
- Equities
- KBPH Stock